Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 9, 2013

Eisai, Emergent BioSolutions, Gilead, Helsinn, Merck Serono, Novartis, QLT

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Cyclacel posts MDS trial results . . . read more

Emergent gets positive results in CLL trial . . . read more

QLT doses first IDA patient . . . read more

Phase III
Merck Serono publishes data for NSCLC trial . . . read more

Filings
Helsinn, Eisai CINV treatment to be reviewed . . . read more

Approvals
Gilead’s HCV treatment approved . . . read more

Health Canada approves Novartis meningitis vaccine . . . read more

Post-Approval
Five-year data support Novartis’ Tasigna in CML . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters